Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in young
reproductive-aged women. PCOS is often associated with obesity and impairs reproductive …

Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in
many biological pathways. Since the discovery of their involvement in endocrine signal …

Myo-inositol has been established as an important growth-promoting factor of mammalian
cells and animals. The role of myo-inositol as a lipotropic factor has been proven, in addition …

Background A couple may be considered to have fertility problems if they have been trying
to conceive for over a year with no success. This may affect up to a quarter of all couples …

Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …

Endometrial cancer (EC) is a deleterious condition which strongly affects a woman's quality
of life. Although aggressive interventions should be considered to treat high-grade EC, a …

Inositols are insulin-sensitizing compounds of promising efficacy in the management of
polycystic ovary syndrome (PCOS). On the one hand, myo-inositol (myo-ins) plays a …

OBJECTIVE: D-chiro-Inositol has been widely used in clinical practice to induce ovulation in
women with polycystic ovary syndrome. Only recent evidence established that this molecule …

Cell signaling via inositol phosphates, in particular via the second messenger myo‐inositol
1, 4, 5‐trisphosphate, and phosphoinositides comprises a huge field of biology. Of the nine …

Aim: In this study, we aim to verify whether the two molecules have a synergistic action by
acting on their specific cellular pathways. The effectiveness in reducing the risk of metabolic …